TipHub

₹1,432.9

▲ +31.67 +2.26%

As of 27 Jul 2026 · delayed

NSE Listed

Global Health Limited (MEDANTA)

Volume: 3,20,038Avg Vol 1W: 3,86,990.6Avg Vol 1M: 1,85,184.952W Range:₹956₹1,456.5
NSE BSE www.medanta.org AI Report
Key Ratios
Checked 2d ago
Market Cap₹37,865 Cr
Current Price₹1,432.9
Previous Close₹1,401.23
High / Low (52w)₹1,456.5 / ₹956
Volume3,20,038
Avg Vol (1W)3,86,990.6
Avg Vol (1M)1,85,184.9
Stock P/E262.74
Book Value₹147.43
Dividend Yield0%
ROE14.1%
ROA9.4%
Revenue (TTM)₹4,410 Cr
Revenue Growth12.7%
Profit Margin12.6%
Total Debt₹264 Cr
Shares Outstanding27 Cr
Face Value₹2
EPS (TTM)₹5.36
P/B9.55
Debt / Equity0.3
50 DMA₹1,291.53
200 DMA₹1,194.45
Day change+2.26%
Price Chart
₹1,432.9▲ 7.62% · 1Y
₹1433₹96148.9L
2025-07-29
2026-07-27

20-day avg volume: 1.9L shares

Pros
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 263.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹861 Cr₹957 Cr₹943 Cr₹931 Cr₹1,031 Cr₹1,099 Cr₹1,121 Cr₹1,159 Cr
EBITDA₹162 Cr₹197 Cr₹205 Cr₹198 Cr₹222 Cr₹201 Cr₹178 Cr₹214 Cr
Net Profit₹106 Cr₹131 Cr₹143 Cr₹101 Cr₹159 Cr₹158 Cr₹95 Cr₹144 Cr
EPS————————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹812 Cr₹3,771 Cr₹803 Cr₹882 Cr₹926 Cr₹940 Cr₹961 Cr₹4,410 Cr
EBITDA₹184 Cr₹762 Cr₹183 Cr₹184 Cr₹178 Cr₹151 Cr₹177 Cr₹0 Cr
Net Profit₹131 Cr₹481 Cr₹93 Cr₹152 Cr₹140 Cr₹80 Cr₹124 Cr₹556 Cr
EPS—17.92——————
Balance Sheet
MetricMar 2018Mar 2019Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1,984 Cr₹2,430 Cr₹2,694 Cr₹3,146 Cr₹4,116 Cr₹4,304 Cr₹4,766 Cr
Total Liabilities₹767 Cr₹1,135 Cr₹1,312 Cr₹1,530 Cr₹1,688 Cr₹1,398 Cr₹1,379 Cr
Equity₹1,217 Cr₹1,295 Cr₹1,382 Cr₹1,616 Cr₹2,428 Cr₹2,906 Cr₹3,388 Cr
Total Debt———————
Cash Flow
MetricMar 2018Mar 2019Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹116 Cr₹233 Cr₹258 Cr₹409 Cr₹751 Cr₹790 Cr₹788 Cr
Investing₹-69 Cr₹-249 Cr₹-239 Cr₹-421 Cr₹-342 Cr₹-441 Cr₹-721 Cr
Financing₹9 Cr₹97 Cr₹-81 Cr₹160 Cr₹346 Cr₹-514 Cr₹-97 Cr
Free Cash Flow₹116 Cr₹233 Cr₹258 Cr₹409 Cr₹751 Cr₹790 Cr₹788 Cr
Shareholding
Promoter 33% Institutions 26.35% Public 40.65%
About Global Health Limited

Healthcare · Healthcare

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup. In addition, the company is involved in trading of pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.

www.medanta.org ↗
Efficiency & Working Capital
ROCE17.6%
Interest Coverage9.7
Dividend Payout—
Debtor Days29 d
Inventory Days7 d
Payable Days19 d
Cash Conversion Cycle16 d
Working Capital Days35 d
Shareholding Details

As of 2026-06-30

Promoter33%
FII9.5%
DII16.9%
Institutions26.4%
Public40.6%
Promoter Pledge0%
No. of Shareholders1,40,531
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters33.1%33.1%33%33%33%33%33%33%33%33%33%33%
FIIs10.7%11.4%12.1%12.9%12.2%12.5%11.8%11.5%11.4%10.5%10.1%9.5%
DIIs10.9%9.7%10.3%10.6%11.1%10.5%11.9%12.2%13%14%14.8%16.9%
Public45.3%45.9%44.6%43.4%43.6%44%43.3%43.2%42.6%42.5%42.1%40.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,16,6271,24,7751,66,2531,55,3071,49,7221,48,6331,54,6881,56,3721,55,8061,51,2411,47,3901,40,531
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Naresh TrehanShareholding of Promoter and Promoter Group33%8.87 Cr
Dunearn Investments (mauritius) Pte LtdPublic Shareholding14.8%3.99 Cr
Sunil SachdevaPublic Shareholding10%2.70 Cr
Rj Corp LimitedPublic Shareholding6.6%1.77 Cr
Invesco India Elss Tax Saver FundPublic Shareholding5.3%1.42 Cr
Kotak Contra FundPublic Shareholding3.5%94,97,519
Government Pension Fund GlobalPublic Shareholding3.2%85,28,455
Uti-healthcare FundPublic Shareholding2%54,09,881
Polaris Healthcare Investments Pte LtdPublic Shareholding1.9%50,00,000
Canara Robeco Mutual Fund A/c Canara Robeco ValuePublic Shareholding1.8%49,09,255
Hdfc Mutual Fund - Hdfc Business Cycle FundPublic Shareholding1.1%28,56,510
Madhu TrehanShareholding of Promoter and Promoter Group0%0
Naveen TrehanShareholding of Promoter and Promoter Group0%0
Neena MalhotraShareholding of Promoter and Promoter Group0%0
Shyel TrehanShareholding of Promoter and Promoter Group0%0
Shonan TrehanShareholding of Promoter and Promoter Group0%0
Aroon PurieShareholding of Promoter and Promoter Group0%0
Naresh Trehan HufShareholding of Promoter and Promoter Group0%0
Rkm Family TrustShareholding of Promoter and Promoter Group0%0
Naresh Trehan Family TrustShareholding of Promoter and Promoter Group0%0
Medanta Institute Of Education And ResearchShareholding of Promoter and Promoter Group0%0
InsaniyatShareholding of Promoter and Promoter Group0%0
Medanta Foundation - Poor And Needy Patients Welfare TrustShareholding of Promoter and Promoter Group0%0
Ntm Family TrustShareholding of Promoter and Promoter Group0%0
Sm Family TrustShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Naresh Kumar TrehanChairman / Executive Director / Managing Director2025
Pankaj Prakash SahniExecutive Director & CEO2025
Hari S BhartiaIndependent Non Exe. Director2025
Praveen MahajanIndependent Non Exe. Director2025
Rajan Bharti MittalIndependent Non Exe. Director2025
RAVI GUPTAIndependent Non Exe. Director2025
RAVI KANT JAIPURIANon Executive Director / Nominee2025
Sunil SachdevaNon-Exec & Non-Independent Dir2025
Vikram Singh MehtaIndependent Non Exe. Director2025
RAHUL RANJANCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Healthcare services₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹22345454
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-30Board Meetings—
dividend2025-08-22₹0.5 (25%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202592003717146
202555000055
202515000216
Substantial Acquisitions (SAST)

1 disclosure(s)

Market20/02/2026 · 10,01,873
Company Information
Incorporated2004
ChairmanNaresh Kumar Trehan
AuditorWalker Chandiok & Co LLP
Investor Email[email protected]
🌐 www.medanta.org ↗

📍 Medanta-Mediclinic, E-18 Defence Colony, New Delhi, New Delhi, 110024

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

M Tek Copper LimitedMcLeod Russel India Ltd.Magellanic Cloud LimitedMcon Rasayan India Ltd.Multi Commodity Exchange of India Ltd.Marvel Decor LimitedMedi Assist Healthcare Services Ltd.Medicamen BiotechMedico Remedies LimitedMedicamen Organics Ltd.Medistep Healthcare Ltd.Medplus Health Services Ltd.All “M” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search